1. Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.
- Author
-
Rice KL, Hormaeche I, Doulatov S, Flatow JM, Grimwade D, Mills KI, Leiva M, Ablain J, Ambardekar C, McConnell MJ, Dick JE, and Licht JD
- Subjects
- Animals, Antineoplastic Agents pharmacology, Cell Survival drug effects, Cell Survival genetics, Cell Survival physiology, Chromatin Immunoprecipitation, Cyclin-Dependent Kinase Inhibitor p19 genetics, Cyclin-Dependent Kinase Inhibitor p19 metabolism, Dual Specificity Phosphatase 6 genetics, Dual Specificity Phosphatase 6 metabolism, Gene Expression Profiling, Gene Expression Regulation, Leukemic drug effects, Genome-Wide Association Study, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells metabolism, Humans, Leukemia, Promyelocytic, Acute genetics, Leukemia, Promyelocytic, Acute metabolism, Leukemia, Promyelocytic, Acute pathology, Mice, Oligonucleotide Array Sequence Analysis, Oncogene Proteins, Fusion metabolism, Oncogene Proteins, Fusion physiology, Protein Binding, Proto-Oncogene Proteins c-myc metabolism, Tretinoin pharmacology, U937 Cells, Xenograft Model Antitumor Assays, Cell Proliferation, Genome, Human genetics, Oncogene Proteins, Fusion genetics, Proto-Oncogene Proteins c-myc genetics
- Abstract
The t(11;17)(q23;q21) translocation is associated with a retinoic acid (RA)-insensitive form of acute promyelocytic leukemia (APL), involving the production of reciprocal fusion proteins, promyelocytic leukemia zinc finger-retinoic acid receptor alpha (PLZF-RARalpha) and RARalpha-PLZF. Using a combination of chromatin immunoprecipitation promotor arrays (ChIP-chip) and gene expression profiling, we identify novel, direct target genes of PLZF-RARalpha that tend to be repressed in APL compared with other myeloid leukemias, supporting the role of PLZF-RARalpha as an aberrant repressor in APL. In primary murine hematopoietic progenitors, PLZF-RARalpha promotes cell growth, and represses Dusp6 and Cdkn2d, while inducing c-Myc expression, consistent with its role in leukemogenesis. PLZF-RARalpha binds to a region of the c-MYC promoter overlapping a functional PLZF site and antagonizes PLZF-mediated repression, suggesting that PLZF-RARalpha may act as a dominant-negative version of PLZF by affecting the regulation of shared targets. RA induced the differentiation of PLZF-RARalpha-transformed murine hematopoietic cells and reduced the frequency of clonogenic progenitors, concomitant with c-Myc down-regulation. Surviving RA-treated cells retained the ability to be replated and this was associated with sustained c-Myc expression and repression of Dusp6, suggesting a role for these genes in maintaining a self-renewal pathway triggered by PLZF-RARalpha.
- Published
- 2009
- Full Text
- View/download PDF